67 related articles for article (PubMed ID: 17116339)
1. Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.
Guillemot J; Guérin M; Thouënnon E; Montéro-Hadjadje M; Leprince J; Lefebvre H; Klein M; Muresan M; Anouar Y; Yon L
PLoS One; 2014; 9(2):e88698. PubMed ID: 24523932
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.
Ramachandran R; Bech P; Murphy KG; Caplin ME; Patel M; Vohra S; Khan MS; Dhillo WS; Sharma R; Palazzo FF; Win Z; Tan T; Khoo B; Meeran K; Frilling A; Ghatei MA; Bloom SR; Martin NM
J Clin Endocrinol Metab; 2015 Apr; 100(4):1520-8. PubMed ID: 25664601
[TBL] [Abstract][Full Text] [Related]
3. CgB promotes EMT and stemness via MAPK pathway in colonic neuroendocrine carcinoma.
Cui J; Ge Y; Sun W; Liu B; Dai C
Am J Cancer Res; 2023; 13(4):1560-1570. PubMed ID: 37168358
[TBL] [Abstract][Full Text] [Related]
4. Circulating Chromogranin B Is Associated With Left Ventricular Functional Recovery After Successful Recanalization of Chronic Total Occlusion.
Shen Y; Aihemaiti M; Shu XY; Yang CD; Chen JW; Dai Y; Ding FH; Yang ZK; Hu J; Zhang RY; Lu L; Wang XQ; Shen WF
Front Cardiovasc Med; 2021; 8():756594. PubMed ID: 35004878
[No Abstract] [Full Text] [Related]
5. Biomarkers in Small Intestine NETs and Carcinoid Heart Disease: A Comprehensive Review.
Kalligeros M; Diamantopoulos L; Toumpanakis C
Biology (Basel); 2021 Sep; 10(10):. PubMed ID: 34681049
[TBL] [Abstract][Full Text] [Related]
6. Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis.
Herold Z; Dank M; Herold M; Nagy P; Rosta K; Somogyi A
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33383764
[TBL] [Abstract][Full Text] [Related]
7. Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment.
Herold Z; Herold M; Rosta K; Doleschall M; Somogyi A
Diabetol Metab Syndr; 2020; 12():61. PubMed ID: 32684986
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice.
Pisani LF; Tontini GE; Marinoni B; Villanacci V; Bruni B; Vecchi M; Pastorelli L
Front Med (Lausanne); 2017; 4():54. PubMed ID: 28540290
[TBL] [Abstract][Full Text] [Related]
9. Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors.
Miki M; Ito T; Hijioka M; Lee L; Yasunaga K; Ueda K; Fujiyama T; Tachibana Y; Kawabe K; Jensen RT; Ogawa Y
Jpn J Clin Oncol; 2017 Jun; 47(6):520-528. PubMed ID: 28334992
[TBL] [Abstract][Full Text] [Related]
10. Consensus on biomarkers for neuroendocrine tumour disease.
Oberg K; Modlin IM; De Herder W; Pavel M; Klimstra D; Frilling A; Metz DC; Heaney A; Kwekkeboom D; Strosberg J; Meyer T; Moss SF; Washington K; Wolin E; Liu E; Goldenring J
Lancet Oncol; 2015 Sep; 16(9):e435-e446. PubMed ID: 26370353
[TBL] [Abstract][Full Text] [Related]
11. The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.
Dobson R; Burgess MI; Banks M; Pritchard DM; Vora J; Valle JW; Wong C; Chadwick C; George K; Keevil B; Adaway J; Ardill JE; Anthoney A; Hofmann U; Poston GJ; Cuthbertson DJ
PLoS One; 2013; 8(9):e73679. PubMed ID: 24069222
[TBL] [Abstract][Full Text] [Related]
12. Increased fecal levels of chromogranin A, chromogranin B, and secretoneurin in collagenous colitis.
Wagner M; Stridsberg M; Peterson CG; Sangfelt P; Lampinen M; Carlson M
Inflammation; 2013 Aug; 36(4):855-61. PubMed ID: 23423580
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).
Ramage JK; Ahmed A; Ardill J; Bax N; Breen DJ; Caplin ME; Corrie P; Davar J; Davies AH; Lewington V; Meyer T; Newell-Price J; Poston G; Reed N; Rockall A; Steward W; Thakker RV; Toubanakis C; Valle J; Verbeke C; Grossman AB;
Gut; 2012 Jan; 61(1):6-32. PubMed ID: 22052063
[TBL] [Abstract][Full Text] [Related]
14. The extended granin family: structure, function, and biomedical implications.
Bartolomucci A; Possenti R; Mahata SK; Fischer-Colbrie R; Loh YP; Salton SR
Endocr Rev; 2011 Dec; 32(6):755-97. PubMed ID: 21862681
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and biochemical studies with region-specific antibodies to chromogranins A and B and secretogranins II and III in neuroendocrine tumors.
Portela-Gomes GM; Grimelius L; Stridsberg M
Cell Mol Neurobiol; 2010 Nov; 30(8):1147-53. PubMed ID: 21046454
[TBL] [Abstract][Full Text] [Related]
16. Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy.
Bech P; Winstanley V; Murphy KG; Sam AH; Meeran K; Ghatei MA; Bloom SR
J Clin Endocrinol Metab; 2008 Apr; 93(4):1246-53. PubMed ID: 18211969
[TBL] [Abstract][Full Text] [Related]
17. Measurements of chromogranin B can serve as a complement to chromogranin A.
Stridsberg M; Eriksson B; Fellström B; Kristiansson G; Tiensuu Janson E
Regul Pept; 2007 Mar; 139(1-3):80-3. PubMed ID: 17116339
[TBL] [Abstract][Full Text] [Related]
18. A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B.
Stridsberg M; Eriksson B; Oberg K; Janson ET
Regul Pept; 2005 Feb; 125(1-3):193-9. PubMed ID: 15582732
[TBL] [Abstract][Full Text] [Related]
19. Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.
Monaghan PJ; Lamarca A; Valle JW; Hubner RA; Mansoor W; Trainer PJ; Darby D
Clin Endocrinol (Oxf); 2016 Mar; 84(3):348-52. PubMed ID: 26608723
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
